Sanai Health Industry Group Co (FRA:WUP0) Enterprise Value: €-27.46 Mil (As of Jul. 14, 2026) ***

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WUP0 Sanai Health Industry Group Co Ltd FRA:WUP0
40 GF Score
Price €0.03
GF Value €0.05
! 5 Warning Signs
View Full Analysis

What is Sanai Health Industry Group Co Enterprise Value?

Sanai Health Industry Group Co FRA:WUP0 40 Enterprise Value is €-27.46 Mil as of Jul. 14, 2026. GuruFocus rates FRA:WUP0 with a GF Score™ of 40/100 and a GF Value™ of €0.05. The stock has 5 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sanai Health Industry Group Co's Enterprise Value is €-27.46 Mil. Sanai Health Industry Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.93 Mil. Therefore, Sanai Health Industry Group Co's EV-to-EBIT ratio for today is 9.38.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sanai Health Industry Group Co's Enterprise Value is €-27.46 Mil. Sanai Health Industry Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.93 Mil. Therefore, Sanai Health Industry Group Co's EV-to-EBITDA ratio for today is 9.38.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sanai Health Industry Group Co's Enterprise Value is €-27.46 Mil. Sanai Health Industry Group Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €10.39 Mil. Therefore, Sanai Health Industry Group Co's EV-to-Revenue ratio for today is -2.64.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Sanai Health Industry Group Co's Enterprise Value is €-27.46 Mil. Sanai Health Industry Group Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €-6.45 Mil. Therefore, Sanai Health Industry Group Co's EV-to-OCF ratio for today is 4.26.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Sanai Health Industry Group Co's Enterprise Value is €-27.46 Mil. Sanai Health Industry Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-6.59 Mil. Therefore, Sanai Health Industry Group Co's EV-to-FCF ratio for today is 4.17.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Sanai Health Industry Group Co  (FRA:WUP0) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Sanai Health Industry Group Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-27.456/-2.926
=9.38

Sanai Health Industry Group Co's current Enterprise Value is €-27.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.93 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Sanai Health Industry Group Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-27.456/-2.926
=9.38

Sanai Health Industry Group Co's current Enterprise Value is €-27.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.93 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Sanai Health Industry Group Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-27.456/10.392
=-2.64

Sanai Health Industry Group Co's current Enterprise Value is €-27.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €10.39 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Sanai Health Industry Group Co's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=-27.456/-6.452
=4.26

Sanai Health Industry Group Co's current Enterprise Value is €-27.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €-6.45 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Sanai Health Industry Group Co's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-27.456/-6.589
=4.17

Sanai Health Industry Group Co's current Enterprise Value is €-27.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-6.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanai Health Industry Group Co Enterprise Value Related Terms


Sanai Health Industry Group Co Enterprise Value Historical Data

* Premium members only.

The historical data trend for Sanai Health Industry Group Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanai Health Industry Group Co Enterprise Value Chart

Sanai Health Industry Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.79 30.43 -17.97 -31.46 -24.93

Sanai Health Industry Group Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.97 -32.38 -31.46 -28.29 -24.93

FRA:WUP0 vs ZTS, UTHR, VTRS: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sanai Health Industry Group Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanai Health Industry Group Co Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanai Health Industry Group Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Sanai Health Industry Group Co's Enterprise Value falls into.


FRA:WUP0
40GF Score
Sanai Health Industry Group Co Ltd FRA:WUP0
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanai Health Industry Group Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Sanai Health Industry Group Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Sanai Health Industry Group Co's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of €-27.46 Mil mean?
Sanai Health Industry Group Co (FRA:WUP0) has a Enterprise Value of €-27.46 Mil as of Jul. 14, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sanai Health Industry Group Co and its competitors.
Is Sanai Health Industry Group Co's Enterprise Value too high?
Sanai Health Industry Group Co's current Enterprise Value is €-27.46 Mil. Overall, Sanai Health Industry Group Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Sanai Health Industry Group Co's Enterprise Value compare to ZTS and UTHR?
Sanai Health Industry Group Co's Enterprise Value of €-27.46 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sanai Health Industry Group Co and its competitors. Sanai Health Industry Group Co's current Enterprise Value is €-27.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanai Health Industry Group Co stock overvalued right now?
Sanai Health Industry Group Co (FRA:WUP0) has a current Enterprise Value of €-27.46 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.03 — trading 50% below its estimated fair value. The current Enterprise Value is €-27.46 Mil. Sanai Health Industry Group Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Sanai Health Industry Group Co (FRA:WUP0), the current Enterprise Value is €-27.46 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sanai Health Industry Group Co (FRA:WUP0) Overvalued in 2026?

Based on GuruFocus' analysis, Sanai Health Industry Group Co stock appears to be undervalued. The current stock price of €0.03 is trading 50% below its estimated GF Value™ of €0.05.

Key valuation signals for FRA:WUP0:

  • Enterprise Value: €-27.46 Mil
  • GF Value™: €0.05 vs. price of €0.03 (50% below fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the FRA:WUP0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sanai Health Industry Group Co Business Description

Other Exchanges 01889:Hong Kong
Address 57 Hung To Road, Unit 5, 7th Floor, Nanyang Plaza, Kwun Tong, Kowloon, Hong Kong, HKG
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products include development, manufacturing, marketing, and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives the majority of its revenue from the PRC.
40GF Score

Get the complete analysis for FRA:WUP0

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.05
GF Value